Observational study / 2014
Alzheimer's disease was linked to lower macular pigment, reduced serum lutein and zeaxanthin, and poorer visual function compared to controls.
This study compared macular pigment (MP), visual function, and serum carotenoid levels between 36 patients with moderate Alzheimer's disease (AD) and 33 controls in the same age range. In the AD group, central MP (at 0.23°) and MP volume were significantly lower than in controls (p < 0.001 for both). AD patients also showed significantly lower best corrected visual acuity, contrast sensitivity, and serum lutein and zeaxanthin concentrations (p < 0.05 for all), alongside a higher occurrence of age-related macular degeneration.
Shows an association, not proof of cause and effect.
- Study type
- Case-control study
- Who was studied
- 36 patients with moderate Alzheimer's disease and 33 age-matched controls
- What was measured
- Macular pigment, visual function (BCVA, CS), serum lutein and zeaxanthin, cognitive function, and AMD status
THE PAPER
Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.
Nolan JM, Loskutova E, Howard AN, Moran R, Mulcahy R, Stack J, Bolger M, Dennison J, Akuffo KO, Owens N, Thurnham DI, Beatty S. J Alzheimers Dis, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.